PharmaShots | Incisive News in 3 Shots

Subscribe Now

PMDA

BMS Receive the CHMP's Positive Opinion Recommending Approval of Opdivo (nivolumab) + Yervoy (ipilimumab) for dMMR or MSI-H mCRC After Prior Chemotherapy

BMS Receive the CHMP's Positive Opinion Recommending Approval of Opdivo (nivolumab) + Yervoy (ipilimumab) for dMMR or MSI-H mCRC A...

May 24, 2021

Merck's Keytruda (pembrolizumab) Receives Two New PMDA's Approvals in Japan

Merck's Keytruda (pembrolizumab) Receives Two New PMDA's Approvals in Japan

August 25, 2020

Lupin and YL Biologics' Etanercept Biosimilar (YLB113) Receive PMDA's Approval for Moderate-to-Severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis (JIA) in Japan

Lupin and YL Biologics' Etanercept Biosimilar (YLB113) Receive PMDA's Approval for Moderate-to-Severe Rheumatoid Arthritis (RA) an...

March 26, 2019

Merck's Keytruda(pembrolizumab) Receives 5 Approvals from PMDA- Japan across 3 Indications

Merck's Keytruda(pembrolizumab) Receives 5 Approvals from PMDA- Japan across 3 Indications

January 3, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us